EZETROL® Re-examination Study (MK0653-175)(COMPLETED)

Organon

Status: Completed

Conditions: Hypercholesterolemia

Study type: Observational

Funder types: Industry

Identifiers

NCT01070953

2010_009

0653-175

Details and patient eligibility

About

This survey is conducted for preparing application materials for re-examination under the Pharmaceutical Affairs Laws and its Enforcement Regulation, its aim is to reconfirm the clinical usefulness of EZETROL® through collecting the safety information according to the Re-examination Regulation for New Drugs.

Enrollment: 4,467 patients

Sex: All

Ages: 10+ years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• Participants Who Receives EZETROL® In Usual Medical Practice

Trial design

4,467 participants in 1 patient group

EZETROL® 10 mg

Description:

Participants with Hypercholesterolemia treated with EZETROL®